+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Veterinary Stereotactic Radiosurgery System Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • PDF Icon

    Report

  • 182 Pages
  • April 2025
  • Region: Global
  • TechSci Research
  • ID: 6075011
Free Webex Call
10% Free customization
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The Veterinary Stereotactic Radiosurgery System Market was valued at USD 3.46 Billion in 2024, and is expected to reach USD 6.21 Billion by 2030, rising at a CAGR of 10.22%. This growth is driven by the increasing prevalence of cancer among companion animals, especially dogs and cats, prompting pet owners to seek advanced and non-invasive treatment solutions. Veterinary stereotactic radiosurgery (SRS) offers precise, high-dose radiation therapy targeted at tumors while minimizing damage to healthy tissue.

Its growing adoption is supported by rising awareness of veterinary oncology options, as well as continuous innovation in devices tailored for animal-specific needs. The market is further fueled by increasing global pet ownership and enhanced standards of pet healthcare, which have expanded access to sophisticated treatments. As veterinary clinics and specialty hospitals adopt more cutting-edge technologies, the demand for SRS systems continues to rise. Additionally, advancements in veterinary diagnostics and oncology are enabling more accurate, personalized care, contributing to the expansion of this market segment across both developed and emerging economies.

Key Market Drivers

Growing Pet Ownership

The expansion of global pet ownership is a pivotal factor in the growth of the Veterinary Stereotactic Radiosurgery System market. With more households adopting pets, there is a corresponding increase in demand for high-quality veterinary healthcare. Particularly in developed regions, pets are increasingly regarded as family members, prompting owners to pursue advanced treatments such as SRS. This trend is also extending to emerging markets where improved access to veterinary services is enabling broader adoption of cutting-edge solutions. As the pet population grows and owners become more informed about specialized care, the demand for precise, non-invasive cancer treatment options like SRS is expected to continue climbing.

Key Market Challenges

Limited Availability of Specialized Veterinary Oncologists

A significant challenge to the broader adoption of veterinary SRS systems is the shortage of trained veterinary oncologists capable of operating the complex equipment and designing effective treatment plans. The precision required for SRS treatment necessitates both technical and clinical expertise, which remains limited in many regions. Additionally, the cost and availability of training programs for veterinary professionals in oncology are insufficient to meet rising demand. These limitations, particularly in rural or underserved areas, hinder the deployment and effective utilization of SRS systems, slowing the market’s overall penetration.

Key Market Trends

Increasing Preference for Non-Invasive Treatments

There is a marked shift toward non-invasive treatment methods in veterinary medicine, driven by heightened concern for animal welfare and the desire for improved recovery outcomes. Stereotactic radiosurgery offers an effective, pain-minimizing alternative to traditional surgery, particularly for treating brain and spinal tumors. With faster recovery times, reduced risk of complications, and minimal hospitalization, SRS is becoming increasingly preferred by pet owners and veterinarians alike. As non-invasive methods become more mainstream in both human and animal healthcare, the veterinary field is embracing technologies that enhance treatment precision and pet comfort.

Key Market Players

  • Avante Health Solutions
  • Accuray Inc.
  • Elekta AB
  • Varian Medical Systems Inc.
  • PetCure Oncology
  • Xstrahl Inc.
  • CVS Group
  • Medtronic PLC
  • Nanovi AS
  • Merck & Co. Inc.

Report Scope:

In this report, the Global Veterinary Stereotactic Radiosurgery System Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below.

Veterinary Stereotactic Radiosurgery System Market, By Product:

  • Gamma Knife
  • LINAC
  • Proton Beam Radiation Therapy (PBRT)/ Flash-RT
  • CyberKnife

Veterinary Stereotactic Radiosurgery System Market, By Application:

  • Brain Tumours
  • Spinal Tumours
  • Other Applications

Veterinary Stereotactic Radiosurgery System Market, By End User:

  • Veterinary Hospitals
  • Veterinary Specialty Clinics
  • Research and Academic Institutions

Veterinary Stereotactic Radiosurgery System Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Stereotactic Radiosurgery System Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. Voice of Customer
5. Global Veterinary Stereotactic Radiosurgery System Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Gamma Knife, LINAC, Proton Beam Radiation Therapy (PBRT)/ Flash-RT, CyberKnife)
5.2.2. By Application (Brain Tumours, Spinal Tumours, Other Applications)
5.2.3. By End User (Veterinary Hospitals, Veterinary Specialty Clinics, Research and Academic Institutions)
5.2.4. By Company (2024)
5.2.5. By Region
5.3. Market Map
6. North America Veterinary Stereotactic Radiosurgery System Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Application
6.2.3. By End User
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Veterinary Stereotactic Radiosurgery System Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Application
6.3.1.2.3. By End User
6.3.2. Mexico Veterinary Stereotactic Radiosurgery System Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Application
6.3.2.2.3. By End User
6.3.3. Canada Veterinary Stereotactic Radiosurgery System Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Application
6.3.3.2.3. By End User
7. Europe Veterinary Stereotactic Radiosurgery System Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Application
7.2.3. By End User
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. France Veterinary Stereotactic Radiosurgery System Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Application
7.3.1.2.3. By End User
7.3.2. Germany Veterinary Stereotactic Radiosurgery System Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Application
7.3.2.2.3. By End User
7.3.3. United Kingdom Veterinary Stereotactic Radiosurgery System Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Application
7.3.3.2.3. By End User
7.3.4. Italy Veterinary Stereotactic Radiosurgery System Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Application
7.3.4.2.3. By End User
7.3.5. Spain Veterinary Stereotactic Radiosurgery System Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Application
7.3.5.2.3. By End User
8. Asia-Pacific Veterinary Stereotactic Radiosurgery System Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Application
8.2.3. By End User
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Veterinary Stereotactic Radiosurgery System Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Application
8.3.1.2.3. By End User
8.3.2. India Veterinary Stereotactic Radiosurgery System Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Application
8.3.2.2.3. By End User
8.3.3. South Korea Veterinary Stereotactic Radiosurgery System Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Application
8.3.3.2.3. By End User
8.3.4. Japan Veterinary Stereotactic Radiosurgery System Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Application
8.3.4.2.3. By End User
8.3.5. Australia Veterinary Stereotactic Radiosurgery System Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Application
8.3.5.2.3. By End User
9. South America Veterinary Stereotactic Radiosurgery System Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Application
9.2.3. By End User
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Veterinary Stereotactic Radiosurgery System Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Application
9.3.1.2.3. By End User
9.3.2. Argentina Veterinary Stereotactic Radiosurgery System Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Application
9.3.2.2.3. By End User
9.3.3. Colombia Veterinary Stereotactic Radiosurgery System Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Application
9.3.3.2.3. By End User
10. Middle East and Africa Veterinary Stereotactic Radiosurgery System Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Application
10.2.3. By End User
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Veterinary Stereotactic Radiosurgery System Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Application
10.3.1.2.3. By End User
10.3.2. Saudi Arabia Veterinary Stereotactic Radiosurgery System Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Application
10.3.2.2.3. By End User
10.3.3. UAE Veterinary Stereotactic Radiosurgery System Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Application
10.3.3.2.3. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Porters Five Forces Analysis
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products
14. Competitive Landscape
14.1. Avante Health Solutions
14.1.1. Business Overview
14.1.2. Company Snapshot
14.1.3. Products & Services
14.1.4. Financials (As Reported)
14.1.5. Recent Developments
14.1.6. Key Personnel Details
14.1.7. SWOT Analysis
14.2. Accuray Inc.
14.3. Elekta AB
14.4. Varian Medical Systems Inc.
14.5. PetCure Oncology
14.6. Xstrahl Inc.
14.7. CVS Group
14.8. Medtronic PLC
14.9. Nanovi AS
14.10. Merck & Co. Inc.
15. Strategic Recommendations16. About the Publisher & Disclaimer

Companies Mentioned

  • Avante Health Solutions
  • Accuray Inc.
  • Elekta AB
  • Varian Medical Systems Inc.
  • PetCure Oncology
  • Xstrahl Inc.
  • CVS Group
  • Medtronic PLC
  • Nanovi AS
  • Merck & Co. Inc.

Table Information